• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Disposerx Partners with Garden State Pharmacy Owners to Offer Drug Disposal Solution and Education in Compliance with Charlie’s Law

Share:

February 17, 2020

DisposeRx, Inc., manufacturer of the market leading at-home medication disposal solution, and Garden State Pharmacy Owners (GSPO), the association of New Jersey independent pharmacies, have entered into a strategic partnership in which DisposeRx will be the preferred vendor.

“With the recent passage of Charlie’s Law, pharmacies and pharmacists need a partner to provide a comprehensive medication disposal program, including information, patient education and product,” said William Simpson, DisposeRx President. “We are meeting this need with our network of more than 1,000 pharmacies throughout New Jersey and look forward to building on that foundation through our partnership with GSPO.”

Charlie’s Law is bi-partisan legislation that requires pharmacists to provide written and oral information on medication disposal, as well as a safe disposal method, for all controlled substances. Governor Phil Murphy signed the bill on Jan. 21, 2020, after more than two years of legislative effort.

“For communities throughout New Jersey, independent pharmacies are an excellent source of guidance related to medications and health,” said Marty Miller, Executive Director of Garden State Pharmacy Owners. “The passage of Charlie’s Law provides us with another opportunity to help our patients and their families stay healthy and safe. We’re endorsing DisposeRx’s packets and its related education program to independent pharmacists because this particular solution is effective and affordable. The DisposeRx team will be a valuable resource, as we ensure compliance related to the new regulations.”

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Source: Biospace

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Fire & Flower Announces Agreement to Acquire Retail Cannabis Store in North Battleford, SaskatchewanFire & Flower Announces Agreement to Acquire Retail Cannabis Store in North Battleford, Saskatchewan
  • Raising the Bar for COVID-19 Data Integrity and Disease SurveillanceRaising the Bar for COVID-19 Data Integrity and Disease Surveillance
  • Global Pulmonary Sarcoidosis Pipeline Insight Market Report 2021 Featuring Novartis, ATyr Pharma, Relief Therapeutics, AI Therapeutics, & SarcoMed USAGlobal Pulmonary Sarcoidosis Pipeline Insight Market Report 2021 Featuring Novartis, ATyr Pharma, Relief Therapeutics, AI Therapeutics, & SarcoMed USA
  • Siemens Healthineers to Acquire Corindus Vascular Robotics for $1.1BSiemens Healthineers to Acquire Corindus Vascular Robotics for $1.1B
  • Europe’s Largest Initiative to Accelerate Therapy Development for Covid-19 LaunchedEurope’s Largest Initiative to Accelerate Therapy Development for Covid-19 Launched
  • Precision Medicine Transforms Rare Cancer TreatmentPrecision Medicine Transforms Rare Cancer Treatment
  • Global Pulmonary Sarcoidosis Pipeline Insight Market Report 2021 Featuring Novartis, ATyr Pharma, Relief Therapeutics, AI Therapeutics, & SarcoMed USA
  • Brainlab Announces the Majority Acquisition of MedphotonBrainlab Announces the Majority Acquisition of Medphoton

Trending This Week

  • Scotland’s Life Sciences Strategy Targets £25bn
  • Nectar Lifesciences Shares Surge on Buyback News
  • SUPRIYA Lifescience Strategic Growth Through Advanced Manufacturing
  • Supriya Lifescience Stock Analysis and Outlook
  • Investment Guide Buy Sell Hold Five Stocks
  • Eiko Lifesciences Financial Performance Analysis 2025

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications